PROTEOSTASIS THERAPEUTICS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROTEOSTASIS THERAPEUTICS IN PUT, CUSIP 74373B959.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for PROTEOSTASIS THERAPEUTICS IN PUT, CUSIP 74373B959.